IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+23.86%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$179M
AUM Growth
+$179M
(+15%)
Cap. Flow
-$570K
Cap. Flow
% of AUM
-0.32%
Top 10 Holdings %
Top 10 Hldgs %
44.86%
Holding
79
New
19
Increased
16
Reduced
19
Closed
13
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$10.7M |
| 2 |
AET
Aetna Inc
AET
|
$6.38M |
| 3 |
Karyopharm Therapeutics
KPTI
|
$3.53M |
| 4 |
Esperion Therapeutics
ESPR
|
$2.65M |
| 5 |
Cardinal Health
CAH
|
$2.45M |
Top Sells
| 1 |
Biogen
BIIB
|
$6.84M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$5.76M |
| 3 |
Zimmer Biomet
ZBH
|
$4.27M |
| 4 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$3.48M |
| 5 |
Elevance Health
ELV
|
$2.88M |
Sector Composition
| 1 | Healthcare | 74.89% |
| 2 | Financials | 3.56% |
| 3 | Energy | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDCO
1
DELISTED
Medicines Co
MDCO
| $12.2M | 6.05% | 250,000 -25,000 | -9% | -$1.22M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $11.2M | 5.54% | 90,000 +10,000 | +13% | +$1.24M |
|
|
SHPG
3
DELISTED
Shire pic
SHPG
| $10.7M | 5.28% | +61,250 | New | +$10.7M |
|
4
Amgen
AMGN
$155B
| $8.2M | 4.06% | 50,000 | – | – |
|
5
Merck
MRK
$210B
| $7.94M | 3.93% | 125,000 +15,000 | +14% | +$953K |
|
|
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $7.37M | 3.65% | 200,000 +25,000 | +14% | +$921K |
|
|
AET
7
DELISTED
Aetna Inc
AET
| $6.38M | 3.15% | +50,000 | New | +$6.38M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.06M | 3% | 50,000 -5,000 | -9% | -$606K |
|
9
Glaukos
GKOS
$5.5B
| $5.13M | 2.54% | 100,000 -20,000 | -17% | -$1.03M |
|
|
10
Ultragenyx Pharmaceutical
RARE
$2.89B
| $5.08M | 2.51% | 75,000 -85,000 | -53% | -$5.76M |
|
|
DERM
11
DELISTED
Dermira, Inc.
DERM
| $4.78M | 2.36% | 140,000 -10,000 | -7% | -$341K |
|
|
OMED
12
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $4.51M | 2.23% | 490,000 -60,000 | -11% | -$553K |
|
13
Merus
MRUS
$4.98B
| $4.27M | 2.11% | 175,000 +25,000 | +17% | +$610K |
|
|
AGN
14
DELISTED
Allergan plc
AGN
| $4.18M | 2.07% | 17,500 +5,000 | +40% | +$1.19M |
|
|
KTWO
15
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.1M | 2.03% | 200,000 +50,000 | +33% | +$1.03M |
|
|
AERI
16
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.86M | 1.91% | 85,000 -30,000 | -26% | -$1.36M |
|
|
17
Karyopharm Therapeutics
KPTI
$61.7M
| $3.53M | 1.75% | +275,000 | New | +$3.53M |
|
|
CLVS
18
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.18M | 1.57% | 50,000 -25,000 | -33% | -$1.59M |
|
19
Abbott
ABT
$231B
| $3.11M | 1.54% | 70,000 -45,000 | -39% | -$2M |
|
|
NUVA
20
DELISTED
NuVasive, Inc.
NUVA
| $2.99M | 1.48% | 40,000 -30,000 | -43% | -$2.24M |
|
|
WBA
21
DELISTED
Walgreens Boots Alliance
WBA
| $2.91M | 1.44% | 35,000 | – | – |
|
22
Supernus Pharmaceuticals
SUPN
$2.53B
| $2.82M | 1.39% | 90,000 -10,000 | -10% | -$313K |
|
|
23
Biogen
BIIB
$19.4B
| $2.73M | 1.35% | 10,000 -25,000 | -71% | -$6.84M |
|
|
24
Esperion Therapeutics
ESPR
$448M
| $2.65M | 1.31% | +75,000 | New | +$2.65M |
|
|
25
Cardinal Health
CAH
$35.5B
| $2.45M | 1.21% | +30,000 | New | +$2.45M |
|